Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
Journal of Immunology Research - Egypt
doi 10.1155/2016/8121985
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Hindawi Limited